BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    CHECK-IT

    MDR report key: 14741245 · Received June 19, 2022

    Report

    Report Number
    3016521623-2022-00229
    Event Type
    Malfunction
    Date Received
    June 19, 2022
    Date of Event
    June 5, 2022
    Report Date
    June 13, 2022
    Manufacturer
    LUCIRA HEALTH, INC.
    Product Code
    QJR
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    NY, US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    PRODUCT HAS NOT BEEN RETURNED. A DHR REVIEW OF THE ASSOCIATED KIT LOT NUMBER (K08A112203223M1) WAS COMPLETED, AND 0 DISCREPANCIES WERE FOUND (ALL LOTS PASSED IN TOTAL PER THE SAMPLING PLAN). A REVIEW OF EXISTING CAPAS, SCARS AND NCMRS WERE COMPLETED AND THERE ARE NO PRIOR RECORDS RELATED TO "FALSE POSITIVE" FAILURE MODE FOR THIS LOT NOR ANY PREVIOUS COMPLAINTS FROM THIS CUSTOMER ASSOCIATED WITH "FALSE POSITIVE" RESULTS PRIOR TO RECEIVED DATE OF (B)(6) 2022. HOWEVER, A FAILURE ANALYSIS (FA) WAS CONDUCTED FOR KIT LOT # K08A112203223M1 ON MAY 18, 2022, ASSOCIATED WITH COMPLAINT (B)(4): 3016521623-2022-00165 THROUGH 3016521623-2022-00176 FOR FURTHER INVESTIGATION INTO A DIFFERENT CUSTOMERS PURCHASING HISTORY (ALL ASSOCIATED KIT LOT NUMBERS UNDERWENT FURTHER INVESTIGATION TESTING DUE TO AN ALLEGED FALSE POSITIVE REPORT). BASED ON REVIEW OF THE PRODUCT'S FMEAS AND RISK ASSESSMENT DOCUMENTATION, FALSE POSITIVE TEST RESULTS ARE A KNOWN POSSIBLE OUTCOME REGARDING THIS ISSUE UNDER EVALUATION, REFER TO FMEA-001 AND FMEA-004. THE COMPLAINT RATE FOR "FALSE POSITIVE" IS UNDER THE EXPECTED THRESHOLD OF 2% (LABEL CLAIM)/1% (INTERNAL WARNING LIMIT). LUCIRA HEALTH WILL CONTINUE TO MONITOR TRENDS RELATED TO FALSE POSITIVE RESULTS IN ACCORDANCE WITH POST-MARKET SURVEILLANCE PROCESS. DHR REVIEW KIT LOT# K08A112203223M1: SAMPLE VIAL LOT DHR REVIEW: 2203138 (ASSOCIATED INTERNAL LOT # 220124-4V) TEST LOT DHRS REVIEW: 2202448, 2202476, 2202475, 2202473, 2202476, 2202475, 2202474, 2202394, 2203073, 2203081, 2203072 (ASSOCIATED INTERNAL LOT # 220124-27U, 220124-30L, 220124-30I, 220124-30C, 220124-30K, 220124-30G, 220124-30F, 220124-12N, 220305-3E, 220305-3G, 220305-3C) FAILURE ANALYSIS TESTING FOR KIT LOT# K08A112203223M1 RESULTS: LUCIRA HEALTH PULLED RETAINS ASSOCIATED WITH KIT LOT NUMBER K08A112203223M1 (50 TEST UNITS, 50 SAMPLE VIALS) FOR TESTING. THE TEST UNITS/SAMPLE VIALS WERE TESTED FOLLOWING WI162 (DEVICE LOT RELEASED-NO TEMPLATE CONTROL (NTC) TESTING) SECTION 9.3. ALL RETAINED DEVICES PASSED WITHOUT ANY FALSE POSITIVE RESULTS. THEREFORE, KIT LOT NUMBER K08A112203223M1 PASSED THE RELEASE CRITERIA IN THE INTERNAL TESTING. BASED ON THE LIMITED INFORMATION AVAILABLE, ROOT CAUSE CANNOT BE DETERMINED. POTENTIAL ROOT CAUSES INCLUDE BUT ARE NOT LIMITED TO: ENVIRONMENTAL CONTAMINATION, LOW VIRAL LOAD, AND/OR DEVICE FAILURE. A SUPPLEMENTAL REPORT WILL BE FILED IF ANY FURTHER INVESTIGATION AND/OR ADDITIONAL INFORMATION IS OBTAINED. BASED ON THE COMPLAINT REVIEW, NO HARM WAS REPORTED WITHIN THE COMPLAINT. THIS DEVICE IS MARKETED UNDER EUA (B)(4) CHECK-IT.

    Description of Event or Problem · 0

    ONE DEVICE REPORTED AS HAVING AN ALLEGED FALSE POSITIVE RESULT. THE COMPLAINANT PEFORMED TWO ADDITIONAL LUCIRA TESTS (1-4 HOURS AFTERWARDS) FOR CONFIRMATION WITH TWO NEGATIVE RESULTS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    202485 CHECK-IT COVID-19 TEST KIT QJR LUCIRA HEALTH, INC. K08A112203223M1

    Patients

    Seq Age Sex Outcome Treatment
    1 Unknown Other